Stem cell and regenerative therapy for diabetes is an investigational approach offered abroad by MTA-verified clinics such as CellsTime Clinique, Giostar Mexico, and Lonvida, and while it is being actively studied for both Type 1 and Type 2 diabetes, it is not an approved cure and should be approached with realistic caution. If you want to compare accredited options, you can browse verified providers here.
This guide explains, in plain and honest terms, what stem cell and regenerative therapy for diabetes actually involves, why some patients travel abroad to explore it, what it tends to cost, and how to evaluate providers carefully. The goal here is information, not persuasion. Diabetes is a serious, lifelong condition, and any decision about experimental treatment should be made alongside your own endocrinologist, with clear eyes about what the science does and does not yet support.
Understanding Stem Cell Therapy for Diabetes
Diabetes comes in two main forms, and it helps to separate them. Type 1 diabetes is an autoimmune condition in which the body's immune system destroys the insulin-producing beta cells in the pancreas, leaving the person dependent on insulin to survive. Type 2 diabetes is primarily a condition of insulin resistance, in which the body still makes insulin but cannot use it effectively, often alongside a gradual decline in insulin production. Because the underlying biology differs, the theory behind regenerative approaches differs too, and neither has been proven to reverse the disease.
Stem cell and regenerative therapy for diabetes generally involves administering cells, most commonly mesenchymal stromal cells, with the hope of modulating the immune response, reducing inflammation, or supporting the health of remaining beta cells. Some research explores whether such approaches might help preserve function in early Type 1 diabetes or improve metabolic control in Type 2 diabetes. It is important to be clear, though, that most of this work remains at the experimental and clinical-trial stage. There is no established, regulator-approved stem cell cure for either type of diabetes, the evidence base is still developing, and outcomes vary considerably from one person to another.
Because of this uncertainty, one principle is non-negotiable: established, evidence-based care must continue. For Type 1 diabetes that means insulin and prescribed management, and for Type 2 diabetes that means the medications, monitoring, and lifestyle plan your doctor has set. No one should stop insulin or prescribed diabetes treatment in favor of stem cell therapy. Regenerative treatment, if pursued at all, should be viewed as an experimental addition to be discussed with your care team, never a replacement for the medicine that keeps you safe.
Why Patients Consider Stem Cell Therapy Abroad
The main reason patients look abroad is availability. In many countries, including the United States, stem cell therapies for diabetes are tightly restricted to approved clinical trials, so patients who want to explore these treatments outside a trial often cannot access them at home. Some clinics in Mexico and other destinations offer regenerative procedures within their own national regulatory frameworks, which makes the treatment reachable for international patients. Availability in another country, however, does not mean a therapy is proven, and it is worth remembering that fewer restrictions can also mean less oversight.
Cost and coordination are also factors. Treatment abroad is often self-funded, and prices in destinations like Mexico can be a fraction of what comparable procedures might cost elsewhere. Many clinics that serve international patients offer English-language coordination alongside the local language, help with scheduling, and support for travel logistics, which lowers the practical barriers to getting care in another country.
None of this changes the core caution. The convenience and lower price of treatment abroad say nothing about whether it will help your diabetes. Approach any clinic that markets regenerative therapy for diabetes with healthy skepticism, and weigh access against the reality that the underlying evidence is still emerging.
What Stem Cell Therapy Costs Abroad
Prices vary widely by clinic, by the number of treatment sessions, and by the specific protocol, but regenerative therapy for diabetes abroad commonly falls somewhere in the mid single digit thousands to low tens of thousands of US dollars. Because these therapies are investigational, they are almost never covered by health insurance, so patients should plan to pay out of pocket and should be wary of financing pressure or any suggestion that a larger package guarantees a better result.
Before committing, insist on a written, itemized quote. It should spell out the type and source of cells, the number of sessions included, all consultations and diagnostic tests, follow-up care, and any costs that are not included, such as travel, lodging, and repeat visits. A clinic that is honest about its evidence and transparent about pricing is a better sign than one that leads with dramatic promises. Be especially cautious of any provider that quotes a cure or guaranteed outcome, because for diabetes no such guarantee is supported by the science.
MTA Verified Providers for Stem Cell Therapy
The providers below are MTA-verified clinics in Mexico that offer regenerative medicine services to international patients. Listing them here is not an endorsement of efficacy for diabetes, and none of them should be understood to cure the disease. Treat these as starting points for careful research and honest conversations, ideally with your endocrinologist involved from the outset.
CellsTime Clinique - MTA Verified
Mexico
- Location: Mexico
- Focus: Regenerative medicine and fertility services for international patients
- Languages: English and Spanish
- International services: International patient coordination for those traveling from abroad
Best for: patients who want a clinic experienced in coordinating regenerative medicine for visitors and who value clear communication in English and Spanish.
View CellsTime Clinique on Better by MTA
Giostar Mexico - MTA Verified
Mexico
- Location: Mexico
- Focus: Stem cell and regenerative therapy, part of the GIOSTAR network
- Languages: English and Spanish
- International services: Care coordination for patients traveling from abroad
Best for: patients who want a provider connected to a broader stem cell network and are comfortable asking detailed questions about protocols and evidence.
View Giostar Mexico on Better by MTA
Lonvida - MTA Verified
Mexico
- Location: Mexico
- Focus: Longevity, wellness, and regenerative medicine
- Languages: English and Spanish
- International services: Programs designed around visiting patients
Best for: patients interested in a wellness and longevity setting who still want to weigh regenerative options against established diabetes care.
Comparing These Providers
All three are Mexico-based, serve international patients in English and Spanish, and coordinate care for people traveling from abroad, so the practical differences often come down to focus and approach. CellsTime Clinique pairs regenerative medicine with fertility services, Giostar Mexico sits within the larger GIOSTAR stem cell network, and Lonvida frames its work around longevity and wellness for visiting patients.
Whichever you consider, apply the same standard to each. Ask what the therapy realistically aims to do for your type of diabetes, what evidence supports it, and how they define success, and treat any promise of a cure as a warning sign rather than a selling point.
Planning Your Stem Cell Therapy Trip Abroad
If you decide to explore treatment abroad, careful planning protects both your health and your money. Keep these priorities front and center:
- Involve your treating physician or endocrinologist before you travel, and share the clinic's proposed protocol so they can weigh in on safety.
- Bring your full medical records, including recent lab work, HbA1c results, current medications, and your diabetes management history.
- Continue your established care throughout, meaning insulin and prescribed management for Type 1 and your prescribed regimen for Type 2, without interruption.
- Hold realistic expectations, understanding that these therapies are experimental, results vary from person to person, and no outcome is guaranteed.
- Plan for follow-up with your own care team after you return, so any changes in your condition are monitored by clinicians who know you.
How to Choose the Right Stem Cell Therapy Provider
Choosing a provider for an investigational therapy calls for extra diligence. Use these criteria to separate responsible clinics from those making overblown claims:
- Look for transparency about the experimental status of the treatment and honest, evidence-based expectations rather than promises of a cure.
- Confirm the clinic communicates clearly in a language you understand and will coordinate directly with your home physician.
- Ask detailed questions about the cell type and source, the protocol, safety monitoring, and how outcomes are tracked.
- Insist on a written, itemized quote and clear informed-consent materials before you commit to anything.
- Verify the provider's standing and reputation, and when you are ready to compare options side by side, get a free quote through Better by MTA.
Ready to Research Your Options Carefully?
Stem cell and regenerative therapy for diabetes is a developing field, not a finished answer, and the most important step you can take is to gather solid information before making any decision. Talk openly with your own endocrinologist, keep your established diabetes care going, and hold on to realistic expectations about what experimental treatment can and cannot do. Approached that way, exploring your options abroad becomes an informed choice rather than a leap of faith.
Better by MTA helps you compare verified providers, request quotes, and coordinate care with confidence, powered by Mastercard payment infrastructure and compliant with HIPAA, GDPR, and SOC 2 standards, so your information and payments are handled securely from first inquiry to follow-up.
By Jonathan Edelheit, CEO and Co-Founder, Medical Tourism Association. Last updated August 2026.
.png)
